Equity
€221,840 from €676,571 in 2017
Equity fell by 67% in 8 years.
MBM PHARMA
Lifetime
20 annual accounts with figures on one time axis, 31 filings since 1995peak €1.0m (2025)
€1.0m▲ 12.6%
peak €354,875 (2025)
€354,875▲ 27.9%
peak €676,571 (2017)
€221,840▼ 10.9%
€650,408▲ 22.6%
peak 12.1 FTE (2022)
9.7 FTE▼ 2.0%
Board4 names since 2000
3 directors and 2 others
Owners
consolidates
Documentsfilings and deeds
26-06-202635 days before the deadline
2025abbreviated format
Gross margin from €900,313 to €1.0mResult from €277,451 to €354,875Dividend €250,000Debts from €530,679 to €650,408Cash from €614,088 to €318,337
Key points
from the 2025 annual accountsResult
€354,875 ▲ 27.9%
The result rose in 2025 from €277,451 to €354,875.
Turnover
≈ €1.7m estimated
The accounts state no turnover.
Debts
€650,408 75% of the balance sheet
Suppliers 26%Taxes and wages 15%Other 59%
Filings
31 annual accounts since 1995
The 2017 accounts came 21 days late. The other nine of the last ten were filed on time.
At the same address
48 companies
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 3,820 companies had the same profile as MBM PHARMA has now. Each dot stands for 10 companies, two years later.
95.1%
were still trading
3.8%
stopped another way
1.0%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,820 companies, not a prediction for MBM PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 11-03-2000
Director, , since 06-12-2013
Director, , since 13-03-2024
- 100%score equity €2.7m (2025) · 2025 annual accounts of
- consolidatesannual accounts 2025
Recent changes
Registered office moved within Auderghem
New registered office: Avenue Tedesco 7-1160 Auderghem · Previous registered office: Avenue Tedesco 26 à 1160 Auderghem · General meeting of 22-12-2025 · Gazette deed
Appointment: (director)
Permanent representative: · General meeting of 13-03-2024 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0454016517
Merger: MBM PHARMA takes over FISCALEX CONSULT
Capital contribution of €72,358.88 · 300 new shares · Resignations: (director) and (director) · General meeting of 31-03-2022 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| MBM PHARMA Auderghem | €872,248 | €1.0m | 25.4% | 9.7 |
| DE BAETS & C° Eeklo | €772,593 | €1.0m | 34.8% | 9 |
| IMAS Fiduciaire Aartselaar | €887,627 | €0.9m | 70.5% | 11 |
| LIEVENS Accountancy Services Bruges | €718,751 | €1.1m | 22.8% | 9.7 |
| TMA INTERNATIONAL Etterbeek | €972,033 | €1.3m | 7.1% | 9 |
| FIDUCIAIRE MOUSCRONNOISE Mouscron | €861,282 | €0.8m | 54.2% | 10 |
| A B F H.-N.A.C. Charleroi | €735,916 | €1.0m | 14.2% | 11.6 |
These companies have the same main activity as MBM PHARMA: certified accountants and tax accountants (NACE 69201). They are comparable in size and age: total assets between €719,000 and €972,000, founded between 1991 and 2000.
Official details
Source: KBO- Status
- Active since 13-12-1994Normal situation
- Registered office
- 50 active companies are registered at this address1 started in the 12 months before. Source: KBO register, as of 13 November 2026.
- Activity
- Certified accountants and tax accountantsNACE 69201
- Joint committee
- 336Liberal professions · annual accounts 2025
- Establishment units
- 2.230.476.4951160 Auderghem, since 01-01-2008
- 2.324.576.1955100 Namur, since 03-12-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 24-11-2023
Annual accounts 2025
- €872,248▲ 11.9%
- Employeeson 31-12-2025
- 10▲ 11.1%
- Filing
- Filed on 26-06-2026, 35 days before the end of the filing period
Insights on MBM PHARMA
MBM PHARMA files the abbreviated format. That format states no turnover. The gross margin rose from €449,261 in 2006 to €1.0m in 2025.
holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about MBM PHARMA
- What is the company number of MBM PHARMA?
- The company number of MBM PHARMA is 0454.016.517. The VAT number is the same number with BE in front: BE 0454.016.517.
- Where is MBM PHARMA based?
- The registered office is at Tedescolaan 7, 1160 Auderghem.Company details
- What does MBM PHARMA do?
- According to the KBO register, the main activity is certified accountants and tax accountants (NACE 69201).
- What is the legal form of MBM PHARMA?
- MBM PHARMA is a private limited company (pre-2019) (BVBA).
- When was MBM PHARMA founded?
- MBM PHARMA was founded on 13-12-1994.
- Is MBM PHARMA still active?
- Yes, MBM PHARMA is an active enterprise in the KBO register.
- How many employees does MBM PHARMA have?
- MBM PHARMA had an average of 9.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does MBM PHARMA fall under?
- In its 2025 annual accounts, MBM PHARMA states joint committee 336 (Liberal professions).
- What is the turnover of MBM PHARMA?
- The turnover in financial year 2025 is ≈ €1.7m. This figure is estimated from the gross margin of €1.0m and 1,584 comparable companies of the same size. It probably lies between €1.2m and €2.9m. It is a rough estimate.
- Is MBM PHARMA profitable?
- In financial year 2025, MBM PHARMA made a profit of €354,875.
- Where can I find the annual accounts of MBM PHARMA?
- MBM PHARMA filed 31 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of MBM PHARMA due?
- MBM PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.